Gadolinium in CKD Stage 4 and 5, Metoprolol and COPD Exacerbations, Vitamin D in Critically Ill Patients, Politics and Mood in Young Physicians

Last Week in Medicine

Contenu fourni par Stephen Jenkins, MD, Austin Rupp, MD, Stephen Jenkins, MD, and Austin Rupp. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Stephen Jenkins, MD, Austin Rupp, MD, Stephen Jenkins, MD, and Austin Rupp ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

5y ago 25:14

MP3•Maison d'episode

Dr. Rupp is back! Today we talk about whether it's safe to give group 2 gadolinium based contrast agents to patients with CKD stage 4 and 5 and whether metoprolol can be used to prevent COPD exacerbations. We also shine some more sunlight on the sunshine vitamin's inability to change any meaningful outcomes, and discuss some interesting data from the Intern Health Study.
Risk of Nephrogenic Systemic Fibrosis in Patients with Stage 4 or 5 CKD Receiving Group II Gadolinium Based Contrast Agent
Metoprolol for the Prevent of Acute Exacerbations of COPD

Early High-Dose Vitamin D3 for Critically Ill, Vitamin D-Deficient Patients
Political events and mood among young physicians
Music from https://filmmusic.io
"Sneaky Snitch" by Kevin MacLeod (https://incompetech.com)
License: CC BY (http://creativecommons.org/licenses/by/4.0/)

58 episodes

#Fitness #Medicine #Stephen Jenkins, MD, Austin Rupp, MD #Austin Rupp #Internal Medicine #Medical Journals #Research Articles #Guidelines #Alternative Health #Mental Health